Home > PJ > Forum

Return to PJ Online Home Page The Pharmaceutical Journal Vol 266 No 7147 p659-660
May 12, 2001

Forum

Guild of Healthcare pharmacists

About 200 participants attended the Guild of Healthcare Pharmacists annual weekend school in Harrogate last month. Frances Thompson and Olumide Cole report

The pharmacy odyssey — developing the staff and the service
Five-year strategy launched for guild
A future without plastic bottles
D Pharm — the holy grail?
Assessing disinfection techniques



The pharmacy odyssey — developing the staff and the service

The plan for pharmacy in the National Health Service, published last September, gave pharmacists the chance to fulfil their professional aspirations. So said Dr JIM SMITH, chief pharmaceutical officer in the Department of Health.

Delivering the keynote address at the weekend school, Dr Smith added that the plan offered an opportunity to improve patient care and the efficiency of the NHS.

Prescribing role

Dr Smith noted that about a quarter of the contents of the Health and Social Care Bill now before the Parliament related to pharmacy, including the provision for extending prescribing rights. He said that although the bill itself would not confer prescribing rights on anyone, it would lead to legislation giving Health Ministers powers to designate new groups of prescribers. A new advisory committee, to be established under the Medicines Act 1968, would advise Health Ministers on extended prescribing rights. The committee would comprise pharmacists, as well as doctors and nurses. Dr Smith asserted that when the Health and Social Care Bill became law, pharmacist prescribing would be given early consideration.

Medicines management

There had been some concern about the potential for overlap between the Department of Health's medicines management framework and the forthcoming study to be carried out by the Audit Commission. Dr Smith gave the assurance that the Department was working closely with the Audit Commission to ensure that the two pieces of work were as complementary as possible. He said that implementation of the Department's framework by an NHS trust between now and the autumn would stand such a trust in good stead if it was selected by the Audit Commission for a local audit. These audits were expected to start in November.

Service quality

Dr Smith acknowledged the effort that had been made by hospital pharmacists to establish quality management over many years. He said that as a result of this effort, the overall standard of prescribing and administration of medicines was high. However, avoidable errors still occurred: about 1.5 per cent of all hospital inpatients were exposed to medication errors, of which about a quarter had the potential to be serious.

An area of service quality highlighted by Dr Smith was unlicensed medicines and specials. There was a need to ensure that unlicensed medicines used in the NHS were produced to a uniformly high standard. A risk assessment review of NHS pharmacy manufacturing was soon to be completed, after which, a document would be published. Dr Smith said that this document would provide a framework for a long overdue, co-ordinated national approach to NHS manufacturing.

Concordance

Dr Smith commented on the fact that health professionals had not been successful in engaging patients as partners in decisions about their medicines. The result was avoidable ill health and waste. For example, up to half of patients with chronic diseases, such as hypertension, did not take their medicines in the proper way. Dr Smith said that better results could be obtained by getting patients to understand and agree with their treatment plan. The benefits of concordance to the NHS included faster and more efficient discharge, higher rates of compliance and a reduction in waste.

Staffing issues

The Department was aware of the efforts being put in by hospital pharmacy managers and their staff to maintain service delivery amid the acute staffing crisis in hospital pharmacy. Dr Smith observed that some of the solutions that had been devised for alleviating the crisis had been creative. For the future, Dr Smith said that there was some hope that the increased number of students in schools of pharmacy would point to a medium-term rise in the number of pharmacists on the register, once the profession managed to get past the “fallow year.” However, new developments in the profession were likely to increase the demand for pharmacists. Therefore, it was important to expend every effort in attracting and retaining new pharmacists and pharmacy technicians. Pay was obviously an important consideration and Dr Smith declared that work on pay modernisation was presently under way.

Other efforts being made by the Department in promoting recruitment included a competition in which schools were asked to design a radio commercial promoting careers in the NHS. There was a specific award for commercials promoting a scientific or technical career.

Conclusion

If pharmacists were successful in achieving the targets set out in the pharmacy plan, concluded Dr Smith, it would mean:

  • More demand for the services of pharmacists and more and better trained staff to deliver those services
  • Better appreciation by the public and by other professionals and managers of what pharmacy could contribute
  • New opportunities to deploy clinical skills, matched by a new emphasis on quality and clinical governance

Back to Top


Five-year strategy launched for guild

A new five-year strategy for the Guild of Healthcare Pharmacists was formally launched at the weekend school. Announcing the strategy, Helen Remington, guild president, said that a major part of this strategy would be the recruitment of more members. The full document, “Guild of Healthcare Pharmacists — strategic direction 2001–2005,” can be found on the guild's website (www.ghp.org.uk).

Mrs Remington also announced the launch of a hospital pharmacy leaflet entitled “Hospital pharmacy — the right medicine,” which was intended for decision-makers and others who could influence the state of hospital pharmacy.

The formation of an IT special interest group was also announced.

Back to Top


A future without plastic bottles

Stephen Freeborn, director of pharmacy, Hope Hospital, Salford, saw a future in which clinicians diagnosed and pharmacists prescribed or treated.

Speaking on the first day of the guild weekend school, Mr Freeborn took his audience back in time to the early days of his career, when pharmacy was a “making” profession. They were times when glycerine suppositories were prepared in batches and tossed up towards the ceiling to determine if they were any good. Subsequently, pharmacists became involved in procurement, quality control and eventually, clinical pharmacy.

Mr Freeborn asked pharmacists to challenge entrenched practices. He shared the experience of his visit to a German pharmacy. A patient had presented a prescription for two items. These had been dispensed by a robotic dispenser in less than 60 seconds. Robotic dispensing had meant that the pharmacist did not have to leave the patient. There was also a much reduced risk of errors.

Mr Freeborn had observed that no labels were stuck to the packs, meaning that the patient had to take some responsibility for their medicines. He said that this was not necessarily good or bad, but was a different approach. The practice was not that strange because, even in the United Kingdom, labels were not stuck to over-the-counter medicine packaging.

Mr Freeborn had also noticed that in the German pharmacy he visited, there had been no bottles in sight, that is, no counting of tablets from a bulk pack into brown plastic bottles. According to Mr Freeborn, with the advent of patient packs, such bottles had no future in pharmacy. “If you have shares in brown plastic companies, sell them,” he joked.

Re-engineering of pharmacy services in the UK was required, Mr Freeborn said. This should involve the use of automation, re-use of patients' own drugs, dispensing for discharge, self-administration of medicines and electronic patient records. Mr Freeborn said that re-engineering would help to:

  • Promote patient-centred care
  • Assist in the provision of more accurate medication histories
  • Allow a more timely supply of discharge medicines and information
  • Contribute to seamless care between primary and secondary care
  • Reduce waste
  • Improve patient concordance

Mr Freeborn urged pharmacy staff to be patient focused, realistic and to be as proactive as possible.

Back to Top


D Pharm — the holy grail?

A doctorate of pharmacy course will allow pharmacists who have a Diploma or Masters degree to continue their postgraduate development, said Professor Peter Taylor, director of pharmacy, Airedale NHS Trust.

Registration was no longer the end product in pharmacy — the environment in which pharmacists were practising was changing so rapidly that continuous education was vital.

Undergraduate degrees had changed greatly, with a shift in emphasis away from purely scientific topics and towards patient care. The preregistration year was still a sort of apprenticeship, and Diplomas and Masters degrees were mostly read by newly qualified pharmacists. In-house training varied throughout the country, so how should pharmacists develop during the 30 years of practise remaining to them? How should future leaders of the profession be developed? A doctorate course might go some way towards filling the gap.

The first part of the doctorate course consisted of a minimum of three one-year rotations, some of which could be undertaken in primary care. These were structured and tutored placements that gave students an insight into different practise and specialties. Progress was assessed using portfolios, case reports and reflective practise journals built up by students. In addition, students were required to present to a panel of senior tutors. Part two took a minimum of two years to complete and involved working in a specialist area with leading-edge practitioners. A research project that was assessed by thesis and viva voce was also required, he explained.

The aim of the doctorate was to develop good practitioners, a research culture and a new breed of reflective practitioners who would operate as consultant pharmacists. Some trusts might decide not to become involved in the course and to concentrate on training preregistration pharmacists or diploma students. It was likely that hospitals and trusts would have to collaborate because the required skills and specialities might not be available in one trust.

Back to Top


Assessing disinfection techniques

Items being prepared in bench-top isolators should be sprayed with 70 per cent industrial methylated spirits (IMS) and “critical” areas (such as the tops of ampoules) should be wiped with 70 per cent isopropyl alcohol (IPA), according to researchers from Wales.

Presenting the 2000 Baxter IV Award lecture, Dr Sarah Hiom, the research and development pharmacist for Wales, St Mary's Hospital, Penarth, said that she had compared four disinfection techniques that were commonly used when transferring items into an isolator. These were spraying items with 70 per cent IMS and using a two-minute or 30-second exposure, wiping items with 70 per cent IPA, and using a combination of spraying with 70 per cent IMS and wiping with 70 per cent IPA. Two methods were then used to validate the disinfection techniques:

  • Total immersion — the item was immersed in sterile water for injections. The water was then sonicated, inoculated on to plates and the number of bacterial colonies grown counted.
  • Roll plating — the item was held in contact with a plate for five seconds. The plate was then incubated and bacterial colonies counted.

Dr Hiom found that the lowest level of bacterial growth was achieved using the combination of IMS and IPA.

Bacterial growth was six times more likely to be detected with the total immersion method than with roll plating, so she recommended that this method of assessing the efficacy of disinfection techniques be used.

Dr Hiom concluded that it did not matter how long items were exposed to IMS for, because the amount of bacterial growth was similar in items that had only been sprayed with IMS, regardless of whether they had been exposed for two minutes or 30 seconds.

Back to Top



©The Pharmaceutical Journal